Recruiting studies: Eltrombopag

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults
Phase 4 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04518475 Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura
NA · 1 location(s) · Sohag University · NCT07093606 Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04993885 Eltrombopag for Chemotherapy-induced Thrombocytopenia
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04600960 Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.
Phase 1/Phase 2 · 1 location(s) · Renata PLC · NCT06531018 Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT04304820 Revolade Tablets Specified Drug-use Survey
Phase N/A · 17 location(s) · Novartis Pharmaceuticals · NCT06287268 A Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombop
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07587723 Eltrombopag for Peripheral Blood Stem Cell Harvest
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT05961410

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.